tru Independence’s Precigen PGEN Stock Holding History

tru Independence’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-49,004	Closed	-$245	–	699
2020 Q2	$245	Sell	49,004 -19,600	-29%	-$66.7K	0.04%	229
2020 Q1	$233	Hold	68,604	–	–	0.04%	191
2019 Q4	$233K	Buy	+68,604	New	+$386K	0.03%	232

Other funds holding PGEN

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

tru Independence's PGEN Position: Q3 2020 in Review

tru Independence sold out of Precigen (PGEN) in Q3 2020, closing a stake of 49,004 shares — an estimated $245 sold.

tru Independence first reported a position in PGEN in Q4 2019 and held it in 3 quarters. The position peaked at $233K in Q4 2019. 159 funds tracked by Wall St. Rank hold PGEN as of Q3 2020.

tru Independence reported no remaining Precigen position as of Q3 2020 after selling out during the quarter.
tru Independence sold 49,004 Precigen shares in Q3 2020, an estimated $245.
tru Independence first reported a position in Precigen in Q4 2019 and held it in 3 quarters.
tru Independence's Precigen position peaked at $233K in Q4 2019.
159 funds tracked by Wall St. Rank held Precigen as of Q3 2020.

Based on tru Independence's 13F filing for Q3 2020, filed 19 Nov 2020.